Langerhans cell histiocytosis (LCH) is an inflammatory myeloid malignancy in the "L-group" histiocytosis. Mitogen-activated protein kinase (MAPK) pathway activating mutations are detectable in nearly all LCH lesions. However, the pathogenic roles of MAPK pathway activation in the development of histiocytosis are still elusive. This review will summarize research concerning the landscape and pathogenic roles of MAPK pathway mutations and related treatment opportunities in Langerhans cell histiocytosis. Video abstract.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764551 | PMC |
| http://dx.doi.org/10.1186/s12964-022-00917-0 | DOI Listing |
Publication Analysis
Top Keywords
langerhans cell
12
cell histiocytosis
12
mapk pathway
12
pathogenic roles
8
roles mapk
8
histiocytosis
5
signaling pathways
4
pathways microenvironment
4
microenvironment targeted
4
targeted treatments
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!